Logo image of CAD.CA

COLONIAL COAL INTERNATIONAL (CAD.CA) Stock Fundamental Analysis

Canada - TSX-V:CAD - CA1956151098 - Common Stock

1.58 CAD
-0.01 (-0.63%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

2

CAD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 810 industry peers in the Metals & Mining industry. While CAD seems to be doing ok healthwise, there are quite some concerns on its profitability. CAD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CAD has reported negative net income.
In the past year CAD has reported a negative cash flow from operations.
In the past 5 years CAD always reported negative net income.
CAD had a negative operating cash flow in each of the past 5 years.
CAD.CA Yearly Net Income VS EBIT VS OCF VS FCFCAD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

CAD has a Return On Assets (-33.77%) which is comparable to the rest of the industry.
With a Return On Equity value of -33.93%, CAD perfoms like the industry average, outperforming 49.38% of the companies in the same industry.
Industry RankSector Rank
ROA -33.77%
ROE -33.93%
ROIC N/A
ROA(3y)-41.58%
ROA(5y)-28.84%
ROE(3y)-41.84%
ROE(5y)-29.03%
ROIC(3y)N/A
ROIC(5y)N/A
CAD.CA Yearly ROA, ROE, ROICCAD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CAD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAD.CA Yearly Profit, Operating, Gross MarginsCAD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

6

2. Health

2.1 Basic Checks

CAD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CAD has more shares outstanding
The debt/assets ratio for CAD has been reduced compared to a year ago.
CAD.CA Yearly Shares OutstandingCAD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CAD.CA Yearly Total Debt VS Total AssetsCAD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

CAD has an Altman-Z score of 1740.64. This indicates that CAD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CAD (1740.64) is better than 99.75% of its industry peers.
CAD has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CAD (0.00) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1740.64
ROIC/WACCN/A
WACCN/A
CAD.CA Yearly LT Debt VS Equity VS FCFCAD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

CAD has a Current Ratio of 66.32. This indicates that CAD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CAD (66.32) is better than 97.90% of its industry peers.
CAD has a Quick Ratio of 66.32. This indicates that CAD is financially healthy and has no problem in meeting its short term obligations.
CAD has a better Quick ratio (66.32) than 97.90% of its industry peers.
Industry RankSector Rank
Current Ratio 66.32
Quick Ratio 66.32
CAD.CA Yearly Current Assets VS Current LiabilitesCAD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for CAD have decreased strongly by -36.14% in the last year.
EPS 1Y (TTM)-36.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAD.CA Yearly EPS VS EstimatesCAD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -0.01 -0.02 -0.03

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CAD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAD.CA Price Earnings VS Forward Price EarningsCAD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAD.CA Per share dataCAD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COLONIAL COAL INTERNATIONAL

TSX-V:CAD (10/16/2025, 7:00:00 PM)

1.58

-0.01 (-0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)10-30 2025-10-30
Inst Owners14.59%
Inst Owner ChangeN/A
Ins Owners26.62%
Ins Owner ChangeN/A
Market Cap287.10M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 13.82
P/tB 13.82
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.77%
ROE -33.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41.58%
ROA(5y)-28.84%
ROE(3y)-41.84%
ROE(5y)-29.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 954.68%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 66.32
Quick Ratio 66.32
Altman-Z 1740.64
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)713.2%
Cap/Depr(5y)6715.17%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.64%
OCF growth 3YN/A
OCF growth 5YN/A